SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013163
Filing Date
2022-05-13
Accepted
2022-05-13 06:45:43
Documents
94
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 768254
2 ex31-1.htm EX-31.1 10933
3 ex32-1.htm EX-32.1 7436
  Complete submission text file 0001493152-22-013163.txt   4769027

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bfri-20220331.xsd EX-101.SCH 52723
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bfri-20220331_cal.xml EX-101.CAL 68663
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bfri-20220331_def.xml EX-101.DEF 186098
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bfri-20220331_lab.xml EX-101.LAB 363387
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bfri-20220331_pre.xml EX-101.PRE 292510
88 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 581350
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40943 | Film No.: 22920183
SIC: 2834 Pharmaceutical Preparations